Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2000
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2100586C Htlv-i and htlv-ii peptide antigens and methods
05/09/2000CA2062340C Process for the industrial-scale preparation of a highly pure standardized human von willebrand factor concentrate appropriate for therapeutic use
05/09/2000CA2058940C Targeted liposomes and methods for liposome-protein coupling
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/09/2000CA2004387C Cyclosporine binding protein and use in an assay for biologically-active cyclosporine
05/09/2000CA1340988C Therapeutic peptides
05/09/2000CA1340985C Peptide derivatives
05/04/2000WO2000025138A2 Methods of diagnosing or prognosing alzheimer's disease
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024913A2 Mn gene and protein
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024910A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography
05/04/2000WO2000024908A1 IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024899A2 Interleukin-1 homolog zil1a4
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000WO2000024893A2 Methods and compositions for the prevention and treatment of anemia
05/04/2000WO2000024891A1 Novel g protein-coupled receptor proteins and dnas thereof
05/04/2000WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/04/2000WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60)
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024869A2 Methods for modulating cell fusion
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024774A2 Growth factor related molecules
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000WO2000024768A2 Genes integrating signal transduction pathways
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024764A1 Lhrh analogues for the treatment of osteoporosis
05/04/2000WO2000024759A1 Systemic delivery of gene products via skin
05/04/2000WO2000024755A1 Ovary-specific genes and proteins
05/04/2000WO2000024754A1 infB POLYPEPTIDE AND POLYNUCLEOTIDES OF STREPTOCOCCUS PNEUMONIAE
05/04/2000WO2000024492A1 Method for purification of a blood component
05/04/2000WO2000024427A1 Remedies for rheumatism containing fadd gene as the active ingredient
05/04/2000WO2000024424A1 Transmucosal sorbefacients comprising polyvalent unsaturated fatty acid and polymer gel and drugs containing the same
05/04/2000WO2000024419A1 Methods for enhancing wound healing
05/04/2000WO2000024418A1 Prevention of muscle mass loss with leptin receptor ligands
05/04/2000WO2000024417A1 A method of regulation
05/04/2000WO2000024416A1 Remedies for bone metabolic errors
05/04/2000WO2000024415A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
05/04/2000WO2000024414A1 Preventives/remedies for liver diseases
05/04/2000WO2000024413A1 A method of treatment
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000024408A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants
05/04/2000WO2000024404A1 Thio-modified aptamer synthetic methods and compositions
05/04/2000WO2000024390A1 Method and composition for modulating amyloidosis
05/04/2000WO2000024378A1 Compositions of microspheres for wound healing
05/04/2000WO2000024377A1 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
05/04/2000WO2000024365A1 Treatment of skin with adenosine or adenosine analog
05/04/2000WO2000024359A2 Use of gndf for treating retinal degeneration
05/04/2000WO2000024267A1 Gelatins with low allergenicity
05/04/2000WO2000024260A1 Enzyme-based fungicide composition
05/04/2000WO2000024254A1 Compositions and methods for modulating expression within smooth muscle cells
05/04/2000WO2000024245A1 REGULATION OF TH2 CELL ACTIVITY BY MODULATION OF NFATp AND NFAT4 ACTIVITY
05/04/2000WO2000018211A8 A novel cochlear gene coch5b2 and uses therefor
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000012072A3 The use of fumaric acid derivatives in transplant medicine
05/04/2000WO2000008047A8 Depsipeptide derivatives bearing piperazinone rings
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006733A3 T cell receptor proteins, nucleic acid molecules, and uses thereof
05/04/2000WO2000006732A3 Polynucleotide encoding an autoantigen associated with endometriosis
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006728A3 Phosphorylation effectors
05/04/2000WO2000006727A3 Human epidermal proteins hepi-1 to hepi-6
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000005263A3 Compounds for use in the treatment of inflammation
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions
05/04/2000WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO1999067286A9 Novel staphylococcus peptides for bacterial interference
05/04/2000WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
05/04/2000WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
05/04/2000WO1999066036A9 Transplants for myocardial scars
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000WO1999062945A9 Peptide antigens for detection of hiv, hcv and other microbial infections
05/04/2000WO1999062934A9 Interferon receptor hkaef92
05/04/2000WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway
05/04/2000WO1999061066A3 Convection-enhanced delivery of aav vectors
05/04/2000WO1999054474A3 Bacterial yiha polypeptide family
05/04/2000WO1999052944A8 G-protein coupled receptors
05/04/2000WO1999047660A9 Retroviral packaging cell line
05/04/2000DE19856882C1 New spermatogenesis protein useful for investigation and modulation of spermatogenesis, particularly for diagnosis and treatment of spermatogenesis disorders
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000DE19850015A1 Proteine der Stomatinfamilie und ihre Verwendung als Zielproteine für die Schm erztherapie Erztherapie proteins of the Stomatinfamilie and their use as target proteins for jewelry
05/04/2000DE19849984A1 Verfahren zur Präparation von Knochenmaterial Process for the preparation of bone material
05/04/2000DE19835910C1 Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17 Gene isolated on the short arm of human chromosome 17
05/04/2000CA2763066A1 Mn gene and protein
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
1 ... 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 ... 3163